Actiq

Actiq is a fentanyl citrate lozenge for oromucosal use, designed for pain management. This medication is manufactured by Teva Pharma B.V. and is available in the EU market.

Actiq is primarily used for the management of breakthrough pain in adults who are already receiving opioid therapy for chronic pain. The lozenge is designed to dissolve in the mouth, allowing for rapid absorption. It is often used in cases where other pain relief methods are insufficient.

Actiq may cause drowsiness, dizziness, nausea, and constipation. Some users may experience headaches or dry mouth. These effects can vary from person to person and may diminish with continued use.

Actiq should be handled with care, as it contains a potent opioid. It is important to follow the prescribed dosage and administration instructions. The lozenge should not be chewed or swallowed whole; it should be allowed to dissolve slowly in the mouth. Keep out of reach of children and pets.

Actiq may interact with other medications, including other opioids, sedatives, and alcohol. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Combining Actiq with alcohol or other central nervous system depressants can increase the risk of severe side effects.